Literature DB >> 12763068

Serotonin type II receptor activation facilitates synaptic plasticity via N-methyl-D-aspartate-mediated mechanism in the rat basolateral amygdala.

A Chen1, C J Hough, H Li.   

Abstract

The modulation of synaptic plasticity by serotonin type II (5-hydroxytryptamine type II (5-HT(2)))-receptor stimulation was explored using intracellular, field potential and Fura-2 fluorescence image recordings in a rat amygdala slice preparation. Bath application of 5HT(2) receptor agonist 1-(2,5)-dimethoxy-4-iodophen-2-aminopropane (DOI) transformed theta-burst-stimulated (TBS) synaptic plasticity from short-term potentiation to long-term potentiation. DOI enhanced N-methyl-D-aspartate (NMDA) receptor-mediated potentials and calcium influx without affecting the resting membrane potential or input resistance of the neurons. In contrast, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate receptor-mediated excitatory synaptic responses were unaffected by DOI. The facilitating effects of DOI were blocked by the 5-HT(2) receptor antagonist, ketanserin, and by the 5-HT(2C)-receptor selective antagonist, RS102221. These results indicate that 5-HT(2)-receptor activation enhances NMDA receptor-mediated synaptic function in the basolateral amygdala (BLA).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763068     DOI: 10.1016/s0306-4522(03)00076-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  23 in total

1.  Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice.

Authors:  Gongliang Zhang; Herborg N Ásgeirsdóttir; Sarah J Cohen; Alcira H Munchow; Mercy P Barrera; Robert W Stackman
Journal:  Neuropharmacology       Date:  2012-06-18       Impact factor: 5.250

2.  Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala.

Authors:  A J McDonald; F Mascagni
Journal:  Neuroscience       Date:  2007-02-28       Impact factor: 3.590

3.  A Discrete Dorsal Raphe to Basal Amygdala 5-HT Circuit Calibrates Aversive Memory.

Authors:  Ayesha Sengupta; Andrew Holmes
Journal:  Neuron       Date:  2019-06-13       Impact factor: 17.173

4.  Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.

Authors:  Antonio Pedro de Mello Cruz; Gilson Pinheiro; Sérgio Henrique Alves; Graziela Ferreira; Marília Mendes; Letícia Faria; Carlos Eduardo Macedo; Vitor Motta; J Landeira-Fernandez
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

5.  Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.

Authors:  Kevin K Ogden; Alpa Khatri; Stephen F Traynelis; Scott A Heldt
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

6.  5-HT2C Receptor Knockdown in the Amygdala Inhibits Neuropathic-Pain-Related Plasticity and Behaviors.

Authors:  Guangchen Ji; Wei Zhang; Lenin Mahimainathan; Madhusudhanan Narasimhan; Takaki Kiritoshi; Xiuzhen Fan; Jigong Wang; Thomas A Green; Volker Neugebauer
Journal:  J Neurosci       Date:  2016-12-23       Impact factor: 6.167

Review 7.  Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functions.

Authors:  Cristiano Bombardi; Giuseppe Di Giovanni
Journal:  Exp Brain Res       Date:  2013-04-17       Impact factor: 1.972

8.  5-HT2C-like receptors in the brain of Xenopus laevis initiate sex-typical fictive vocalizations.

Authors:  H J Yu; A Yamaguchi
Journal:  J Neurophysiol       Date:  2009-05-27       Impact factor: 2.714

Review 9.  Serotonergic mechanisms in addiction-related memories.

Authors:  Bríd A Nic Dhonnchadha; Kathryn A Cunningham
Journal:  Behav Brain Res       Date:  2008-07-01       Impact factor: 3.332

10.  Serotonergic pharmacotherapy promotes cortical reorganization after spinal cord injury.

Authors:  Patrick D Ganzer; Karen A Moxon; Eric B Knudsen; Jed S Shumsky
Journal:  Exp Neurol       Date:  2012-12-19       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.